From a recent Mad Money show:

"I think this is a great way to play a slowing economy. I think it's a buy."

Some spinoffs that undergo additional restructuring are also are of interest to Keeley. The firm bought Louisville, Ky.-based PharMerica (PMC), which was created in 2007 from the merger of two leading institutional pharmacy businesses -- PharMerica Long-Term Care and Kindred Pharmacy Services. PharMerica Long-Term was spun out from AmerisourceBergen (ABC), a drug wholesaler. It then was merged with Kindred. The new company operates 115 institutional pharmacies that service 340,000 beds. "So in addition to the benefits of a spinoff and restructuring, you have a demographic play as the population ages," says health-care specialist Woodyatt. Small Cap Value bought it in April at around 15. It has since risen to about 24. The Street estimates earnings of 78 cents a share this fiscal year and $1.04 next year.

From a recent Mad Money show:

"I think this is a great way to play a slowing economy. I think it's a buy."

Cramer put PharMerica (PMC) in the "don't buy" camp. This company is too new and unseasoned to invest in, he said, adding he saw no compelling reason to take on the extra risk.